The Effect of Nirmatrelvir-Ritonavir on Short- and Long-term Adverse Outcomes From COVID-19 Among Patients With Kidney Disease: A Propensity Score-Matched Study: Open Forum Infect Dis. 2024 Dec 31;12(1):ofae756. doi: 10.1093/ofid/ofae756
Related Posts
Khan A, Khan M, Hammadeh BM, Ishaq MU, Naveed H, Allana S, Fudim M, Mentz RJ, Fonarow GC, Biering-Sørensen T. Influenza vaccination in patients with[...]
Kobashigawa J, Zuckermann A, Potena L, Ardehali A, Berman M, Chang PP, Esmailian F, Farr M, Hall S, Hsich E, Khush K, Kittleson M, Leprince[...]
Watson KE, Fonarow GC. The 2026 American College of Cardiology/American Heart Association Multisociety Guideline on the Management of Dyslipidemia: A More Precise-But More Complicated-Framework for[...]